疑似冠心病患者冠状动脉钙化与动脉粥样硬化进展的关系
698例有症状疑似冠心病患者间隔3.5至4.0年行系列冠状动脉CT血管成像,量化斑块体积及成分。基线CAC从0到≥400,总斑块体积从30.4增至522.4 mm³,阻塞性CAD患病率从1.4%升至49.1%;CAC≥100者斑块增长及新发/加重狭窄更多,CAD事件风险从无CAC的3.3%升至CAC≥400的21.9%。
要点
- CAC评分为0时97.9%的总斑块为非钙化斑块,CAC<100者非阻塞性CAD常见。
- 基线CAC≥100者随访CTA上斑块体积增长及新发或加重狭窄更多。
- CAD事件风险随CAC评分升高呈梯度增加,从3.3%至21.9%。
核心结论
- CAC不能完美反映动脉粥样硬化疾病负担,但其亚组呈现早期至晚期疾病进展的致病模式,并可对长期预后风险进行分层。
研究设计与样本
- 研究纳入698例有症状疑似冠心病患者,行间隔3.5至4.0年的系列冠状动脉CTA,量化斑块及成分亚组,阻塞性CAD定义为狭窄≥50%,采用多变量线性回归分析斑块进展、Cox比例风险模型评估CAD事件风险(中位随访10.7年)。
关键影像表现/征象
- 基线CAC评分从0到≥400,总斑块体积从30.4 mm³增至522.4 mm³(P < 0.001)。
- 基线CAC评分为0者97.9%的总斑块为非钙化斑块。
- 基线CAC<100者非阻塞性CAD常见:CAC 0组为40%,CAC 1-99组为89%,斑块以非钙化为主。
- 随访冠状动脉CTA显示,基线CAC≥100者斑块体积增长(P < 0.001)及新发或加重狭窄(P < 0.001)更多。
- 无CAC者非钙化斑块增长不成比例,钙化斑块每增加1 mm³,非钙化斑块体积增加5.5 mm³;CAC≥400者钙化斑块增长不成比例,钙化斑块体积增加为非钙化斑块的15.7倍。
诊断标准与关键数值
- 阻塞性CAD定义为冠状动脉狭窄≥50%。
- 基线CAC评分从0到≥400,阻塞性CAD患病率从1.4%增至49.1%(P < 0.001)。
- CAD事件风险随CAC评分梯度增加,无CAC者为3.3%,CAC≥400者为21.9%(P < 0.001)。
临床应用与阅片要点
- CAC评分为0时仍可能存在大量非钙化斑块,阅片时需评估非钙化斑块负荷。
- 基线CAC<100者非阻塞性CAD常见,报告时应描述非钙化斑块及狭窄情况。
- 基线CAC≥100者随访中斑块体积增长及狭窄进展更多,CAD事件风险随CAC评分升高而增加。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Among symptomatic patients, it remains unclear whether a coronary artery calcium (CAC) score alone is sufficient or misses a sizeable burden and progressive risk associated with obstructive and nonobstructive atherosclerotic plaque.
OBJECTIVES: Among patients with low to high CAC scores, our aims were to quantify co-occurring obstructive and nonobstructive noncalcified plaque and serial progression of atherosclerotic plaque volume.
METHODS: A total of 698 symptomatic patients with suspected coronary artery disease (CAD) underwent serial coronary computed tomographic angiography (CTA) performed 3.5 to 4.0 years apart. Atherosclerotic plaque was quantified, including by compositional subgroups. Obstructive CAD was defined as ≥50% stenosis. Multivariate linear regression models were used to measure atherosclerotic plaque progression by CAC scores. Cox proportional hazard models estimated CAD event risk (median of 10.7 years of follow-up).
RESULTS: Across baseline CAC scores from 0 to ≥400, total plaque volume ranged from 30.4 to 522.4 mm3 (P < 0.001) and the prevalence of obstructive CAD increased from 1.4% to 49.1% (P < 0.001). Of those with a 0 CAC score, 97.9% of total plaque was noncalcified. Among patients with baseline CAC <100, nonobstructive CAD was prevalent (40% and 89% in CAC scores of 0 and 1-99), with plaque largely being noncalcified. On the follow-up coronary CTA, volumetric plaque growth (P < 0.001) and the development of new or worsening stenosis (P < 0.001) occurred more among patients with baseline CAC ≥100. Progression varied compositionally by baseline CAC scores. Patients with no CAC had disproportionate growth in noncalcified plaque, and for every 1 mm3 increase in calcified plaque, there was a 5.5 mm3 increase in noncalcified plaque volume. By comparison, patients with CAC scores of ≥400 exhibited disproportionate growth in calcified plaque with a volumetric increase 15.7-fold that of noncalcified plaque. There was a graded increase in CAD event risk by the CAC with rates from 3.3% for no CAC to 21.9% for CAC ≥400 (P < 0.001).
CONCLUSIONS: CAC imperfectly characterizes atherosclerotic disease burden, but its subgroups exhibit pathogenic patterns of early to advanced disease progression and stratify long-term prognostic risk.
引用
- Hollenberg, Lin, Blaha, et al. Relationship Between Coronary Artery Calcium and Atherosclerosis Progression Among Patients With Suspected Coronary Artery Disease. JACC Cardiovasc Imaging. 2022. PMID: 35680215. doi:10.1016/j.jcmg.2021.12.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。